Veradigm (NASDAQ:MDRX) Now Covered by Analysts at StockNews.com

Analysts at StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX) in a report released on Thursday. The firm set a “hold” rating on the software maker’s stock.

A number of other equities analysts have also recently issued reports on MDRX. TD Cowen dropped their price objective on Veradigm from $26.00 to $15.00 and set a “buy” rating for the company in a report on Tuesday, May 28th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $10.00 target price (down from $15.00) on shares of Veradigm in a research note on Tuesday, March 19th. Five investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, Veradigm presently has an average rating of “Hold” and an average target price of $12.00.

Veradigm Stock Performance

Shares of NASDAQ:MDRX opened at $9.50 on Thursday. The business has a 50 day simple moving average of $8.67 and a two-hundred day simple moving average of $8.63. Veradigm has a 1 year low of $5.01 and a 1 year high of $14.09.

Institutional Investors Weigh In On Veradigm

Hedge funds have recently made changes to their positions in the company. TFO Wealth Partners LLC raised its holdings in shares of Veradigm by 105,280.0% in the fourth quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker’s stock valued at $52,000 after acquiring an additional 5,264 shares in the last quarter. Gladius Capital Management LP raised its holdings in shares of Veradigm by 135.0% in the 4th quarter. Gladius Capital Management LP now owns 6,245 shares of the software maker’s stock valued at $66,000 after purchasing an additional 3,587 shares in the last quarter. Headlands Technologies LLC lifted its position in shares of Veradigm by 14,907.7% in the 4th quarter. Headlands Technologies LLC now owns 9,755 shares of the software maker’s stock worth $102,000 after purchasing an additional 9,690 shares during the period. Meadow Creek Wealth Advisors LLC bought a new position in shares of Veradigm during the first quarter valued at approximately $83,000. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new position in Veradigm during the third quarter valued at approximately $189,000.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.